[{"address1": "2000 Sierra Point Parkway", "address2": "Suite 400", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "415 798 8589", "website": "https://www.tempesttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.", "fullTimeEmployees": 24, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen R. Brady J.D., LLM", "age": 55, "title": "CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 894300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas  Maestas", "age": 44, "title": "CFO, Head of Corporate Strategy & Secretary", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 465615, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel  Whiting M.D., Ph.D.", "age": 58, "title": "Executive VP, Chief Medical Officer and Head of R&D", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 671387, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Trojanowski CPA", "age": 36, "title": "Corporate Controller, Treasurer & Principal Accounting Officer", "yearBorn": 1989, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.65, "open": 2.67, "dayLow": 2.62, "dayHigh": 2.78, "regularMarketPreviousClose": 2.65, "regularMarketOpen": 2.67, "regularMarketDayLow": 2.62, "regularMarketDayHigh": 2.78, "payoutRatio": 0.0, "beta": -2.232, "forwardPE": -1.9710145, "volume": 91053, "regularMarketVolume": 91053, "averageVolume": 118830, "averageVolume10days": 75360, "averageDailyVolume10Day": 75360, "bid": 1.98, "ask": 3.44, "bidSize": 2, "askSize": 2, "marketCap": 13401881, "fiftyTwoWeekLow": 2.4, "fiftyTwoWeekHigh": 13.13, "allTimeHigh": 162893.25, "allTimeLow": 2.21, "fiftyDayAverage": 4.3483, "twoHundredDayAverage": 7.352505, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 12968238, "profitMargins": 0.0, "floatShares": 4191112, "sharesOutstanding": 4927161, "sharesShort": 185406, "sharesShortPriorMonth": 379220, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0376, "heldPercentInsiders": 0.00099, "heldPercentInstitutions": 0.1189, "shortRatio": 1.79, "shortPercentOfFloat": 0.0377, "impliedSharesOutstanding": 4927162, "bookValue": 1.429, "priceToBook": 1.9034289, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -36054000, "trailingEps": -9.73, "forwardEps": -1.38, "lastSplitFactor": "1:13", "lastSplitDate": 1744156800, "enterpriseToEbitda": -0.359, "52WeekChange": -0.76411414, "SandP52WeekChange": 0.14725316, "quoteType": "EQUITY", "currentPrice": 2.72, "recommendationKey": "none", "totalCash": 7514000, "totalCashPerShare": 1.692, "ebitda": -36166000, "totalDebt": 8405000, "quickRatio": 2.132, "currentRatio": 2.299, "debtToEquity": 132.446, "returnOnAssets": -0.89316005, "returnOnEquity": -4.0503297, "freeCashflow": -20340750, "operatingCashflow": -33395000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TPST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Tempest Therapeutics, Inc.", "longName": "Tempest Therapeutics, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1768608292, "regularMarketTime": 1768597201, "exchange": "NCM", "messageBoardId": "finmb_552715229", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.64151, "regularMarketPrice": 2.72, "fiftyDayAverageChange": -1.6283, "fiftyDayAverageChangePercent": -0.37446818, "twoHundredDayAverageChange": -4.6325054, "twoHundredDayAverageChangePercent": -0.6300581, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Tempest Therapeutics Inc.", "nameChangeDate": "2026-01-16", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1352730600000, "postMarketChangePercent": -2.7389736, "postMarketPrice": 2.6455, "postMarketChange": -0.074500084, "regularMarketChange": 0.0699999, "regularMarketDayRange": "2.62 - 2.78", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 118830, "fiftyTwoWeekLowChange": 0.31999993, "fiftyTwoWeekLowChangePercent": 0.1333333, "fiftyTwoWeekRange": "2.4 - 13.13", "fiftyTwoWeekHighChange": -10.41, "fiftyTwoWeekHighChangePercent": -0.7928408, "fiftyTwoWeekChangePercent": -76.411415, "dividendDate": 1544400000, "earningsTimestamp": 1762349400, "earningsTimestampStart": 1762349400, "earningsTimestampEnd": 1762349400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -9.73, "epsForward": -1.38, "displayName": "Tempest Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-17"}]